In contrast, with the more complex HGF treated tumor cell population comprised of 89% EGFRL858R, 10% EGFRL858RBRAFV600E, 1% EGFRL858R, T790M, only combination strategies with switching horizons of 10 day or shorter induced a response (Fig. 5B). This evidence concerns the gene HGF and neoplasm.